Document is current
Any future updates will be listed below
-
Authors
Di Bernardo, Matteo
Kern, Roshan S.
Cepeda Diaz, Ana Karla https://orcid.org/0000-0002-2033-461X
Mallar, Alexa
Choi, Samuel J.
Nutter-Upham, Andrew
Lourido, Sebastian https://orcid.org/0000-0002-5237-1095
Blainey, Paul C. https://orcid.org/0000-0002-4889-8783
Cheeseman, Iain https://orcid.org/0000-0002-3829-5612
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM126930)
Chan Zuckerberg Initiative, Whitehead Innovation Initiative
National Science Foundation (000955563)
Massachusetts Life Sciences Center (Data Science Internship Program)
Massachusetts Institute of Technology (UROP Program)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG009283)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R01AI144369)
- License Information
-
More Information
Article History
Received: 6 June 2025
Accepted: 15 May 2026
First Online: 30 May 2026
Competing interests
: P.C.B. is a consultant to or holds equity in 10X Genomics, General Automation Lab Technologies/Isolation Bio, Next Gen Diagnostics, Cache DNA, Concerto Biosciences, Stately Bio, Ramona Optics, Bifrost Biosystems, and Amber Bio. His laboratory has received research funding from Calico Life Sciences, Merck, and Genentech for work related to genetic screening. The remaining authors declare no competing interests.
